These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3123145)

  • 21. Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis.
    Paramo JA; de Boer A; Colucci M; Jonker JJ; Collen D
    Thromb Haemost; 1985 Oct; 54(3):725. PubMed ID: 3937271
    [No Abstract]   [Full Text] [Related]  

  • 22. [Plasma fibrinolysis inhibitors].
    Nowak S; Nowak A
    Pol Arch Med Wewn; 1985 Feb; 73(2):113-21. PubMed ID: 2410893
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship between preoperative status of the fibrinolytic system and occurrence of deep vein thrombosis after major abdominal surgery.
    Mellbring G; Dahlgren S; Wiman B; Sunnegårdh O
    Thromb Res; 1985 Jul; 39(2):157-63. PubMed ID: 2411000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coagulation physiological findings in thrombosis].
    Nilsson IM; Cronberg S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):124-9. PubMed ID: 50976
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation of fibrinolysis in aortic surgery.
    Gomez MJ; Carroll RC; Hansard MR; Kidd M; Goldman MH
    J Vasc Surg; 1988 Oct; 8(4):384-8. PubMed ID: 3139896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fibrinolytic properties of the blood of rheumatoid arthritis patients].
    Erov NK
    Lab Delo; 1986; (7):417-20. PubMed ID: 2429032
    [No Abstract]   [Full Text] [Related]  

  • 27. Blocking of the fibrinolytic antiactivator by substituted benzoates.
    Nanninga L; Guest M
    Life Sci; 1974 Jun; 14(12):2507-11. PubMed ID: 4283613
    [No Abstract]   [Full Text] [Related]  

  • 28. [Endothelium, thrombosis and fibrinolysis].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1997 Dec; 47(20):2227-31. PubMed ID: 9616910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
    Bachmann F
    Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immobilization of the plasminogen activator streptokinase and its fibrinolytic effects in vivo.
    Mercer LC; Everse KE; Holmes AW; Everse J
    Thromb Res; 1978 Dec; 13(6):931-40. PubMed ID: 107613
    [No Abstract]   [Full Text] [Related]  

  • 31. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke.
    Andreotti F; Davies GJ; Hackett DR; Khan MI; De Bart AC; Aber VR; Maseri A; Kluft C
    Am J Cardiol; 1988 Sep; 62(9):635-7. PubMed ID: 3137799
    [No Abstract]   [Full Text] [Related]  

  • 32. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB; McGehee WG; Feinstein DI
    Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differentiation of a normal population and of a cohort of patients presenting with a history of idiopathic thromboembolism as identified with fibrinolytic tests].
    Nicoloso G; Hauert J; Kruithof EK; van Melle G; Bachmann F
    Schweiz Med Wochenschr; 1988 Jan; 118(4):122-4. PubMed ID: 3125604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
    Stalder M; Hauert J; Bachmann F
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen activator inhibitor in the blood of patients with coronary artery disease.
    Paramo JA; Colucci M; Collen D; van de Werf F
    Br Med J (Clin Res Ed); 1985 Aug; 291(6495):573-4. PubMed ID: 3929877
    [No Abstract]   [Full Text] [Related]  

  • 36. Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis.
    Glas-Greenwalt P; Kant KS; Dosekun A; Frazier J; Allen C; Pollak VE
    J Lab Clin Med; 1985 Jan; 105(1):99-107. PubMed ID: 3871465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities of fibrinolysis in essential hypertension.
    Ettenger MM; MacCarthy EP; Glas-Greenwalt P; Clyne DH; Pollak VE
    J Hypertens Suppl; 1984 Dec; 2(3):S175-8. PubMed ID: 6242555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic fibrinolytic agents.
    Davidson JF; Walker ID
    Prog Cardiovasc Dis; 1979; 21(5):375-96. PubMed ID: 154124
    [No Abstract]   [Full Text] [Related]  

  • 39. Coagulation and fibrinolysis in rats poisoned with mercuric chloride.
    Michalska M; Mirowski M; Wierzbicki R
    Pol J Pharmacol Pharm; 1988; 40(4):365-71. PubMed ID: 3146750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of ethanol and acetaldehyde on fibrinolytic system (examinations in vitro).
    Skrzydlewska E; Worowski K
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():163-73. PubMed ID: 6242841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.